EVAADO: Qualitative Evaluation of Therapeutic Alliance in Adolescent Psychiatry

Sponsor
Centre Hospitalier Victor Dupouy (Other)
Overall Status
Unknown status
CT.gov ID
NCT03288649
Collaborator
(none)
180
2
29.9
90
3

Study Details

Study Description

Brief Summary

Context: Psychiatric disorders (anorexia nervosa, depression, anxiety based school refusal) are a major public health concern in adolescence. Their treatment is a challenge for the families, the health care system and society. The treatment is complex and non-standardized. In clinical practice, the relational dimension between the stakeholders is recognized by all. Nevertheless no study has ever crossed their perspectives about therapeutic alliance in adolescent psychiatry.

Objective: to explore, within a qualitative approach, how a therapeutic alliance is established in three different clinical situations according to the adolescents, their parents and their physicians by crossing their perspectives.

Methods: This is a national (France) multi-center qualitative study based on 180 semi-structured interviews. Participants (purposively selected until data saturation) came from three different sub-samples: (i) adolescents with anorexia nervosa (N =20) plus their parents (N=20) and their physicians (N=20), (ii) adolescents with depressions (N=20) plus their parents (N=20) and their physicians (N=20), and (iii) adolescents with anxiety-based school refusal (N=20) plus their parents (N=20) and their physicians (N=20). Data are collected through open ended semi structured interviews and independently analyzed with NVivo V.11 software by three researchers according to the principles of Interpretative Phenomenological Analysis.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    180 participants
    Observational Model:
    Other
    Time Perspective:
    Prospective
    Official Title:
    Qualitative Evaluation of Therapeutic Alliance in Adolescent Psychiatry: Crossing Perspectives of Adolescents, Parents and Physicians
    Actual Study Start Date :
    Jan 1, 2016
    Anticipated Primary Completion Date :
    Dec 31, 2017
    Anticipated Study Completion Date :
    Jun 30, 2018

    Arms and Interventions

    Arm Intervention/Treatment
    Anorexia nervosa

    adolescents with anorexia nervosa (N=20 ?), their parents (N=20), their physicians (N=20)

    Anxiety based school refusal

    adolescents with anxiety based school refusal (N=20 ?), their parents (N=20), their physicians (N=20)

    Depression

    adolescents with depression (N=20 ?), their parents (N=20), their physicians (N=20)

    Outcome Measures

    Primary Outcome Measures

    1. to describe the facilitators of therapeutic alliance within adolescent psychiatry using a qualitative approach [2 years]

      qualitative methodology using verbal data analysis of semi-structured interviex

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    12 Years to 18 Years
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • adolescents, boys and girls, aged 12 to 18 years, speaking fluent French, with (i) anorexia nervosa according to DSM 5 criteria (ii) depressive disorders (dysthymia, depressive episode) according to DSM 5 criteria (iii) anxiety-based school refusal according to four criteria:
    1. refusal to attend school (to operationalize this first criterion, adolescents were included if they had not attended school at all for at least one month before starting treatment); (2) presence of a DSM-5 anxiety disorder (except obsessive-compulsive or post-traumatic stress disorders) with emotional upset at the prospect of attending school; (3) absence of a DSM-5 conduct disorder; and (4) parental knowledge of the adolescent's whereabouts during the period of non-attendance.

    that led to treatment that had begun at least six months earlier and clinically determined to be well enough to participate in a research interview.

    • receiving treatment for at least 6 months

    • one parent at least agrees to participate

    Exclusion Criteria:
    • acute symptoms and serious somatic and/or psychiatric co-morbidities

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 CHVictorDupouy Argenteuil France 95100
    2 CHU Rouen Rouen France 76000

    Sponsors and Collaborators

    • Centre Hospitalier Victor Dupouy

    Investigators

    • Principal Investigator: Anne Revah-Levy, MD PhD, Paris diderot University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Anne Revah-Levy, Pr Anne Revah-Levy, Centre Hospitalier Victor Dupouy
    ClinicalTrials.gov Identifier:
    NCT03288649
    Other Study ID Numbers:
    • 20140600001072
    First Posted:
    Sep 20, 2017
    Last Update Posted:
    Sep 20, 2017
    Last Verified:
    Sep 1, 2017
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 20, 2017